🌍September 16, 2026·2d agoResearch

A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901).

Publisher

Europe PMC

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: Europe PMC
Region: EU
Scope: Research
Published: September 16, 2026
Language: EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on europepmc.org

Leave the platform to read the original full article on the publisher site.

Source: Europe PMC

Scope: Research

Open original article

Related coverage

More related coverage

Policlinico di Milano/1d ago

[17.09] Il Policlinico di Milano si illumina di arancione per la Giornata Nazionale della Sicurezza delle Cure

Universitätsklinikum Heidelberg/1d ago

Informationstag Pankreaszysten: Wann ist eine Behandlung notwendig?

UNMC/1d ago

MMI marks five years in state-of-the-art building